{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:43:21Z","timestamp":1778856201309,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To date, there are few studies that have evaluated the prognostic impact of changes in abdominal obesity or weight on long-term adverse kidney outcomes in non-alcoholic fatty liver disease (NAFLD). We investigated the effect of changes in waist-to-hip ratio (WHR) and body weight (BW) on chronic kidney disease (CKD) development, especially in non-obese NAFLD patients. We included 6,137 participants from a community-based prospective cohort with 12-year follow-up in Korea. NAFLD patients were categorized according to time-averaged percent changes in WHR and BW (\u2264\u22125%, &gt;\u22125% to &lt;5%, and \u22655%). Compared to non-obese controls, non-obese NAFLD was significantly associated with an increased risk of incident CKD (hazard ratio [HR]\u2009=\u20091.238, 95% confidence interval [CI]\u2009=\u20091.006\u20131.524). In 1,563 NAFLD patients, compared to patients with minimal changes in WHR (&gt;\u22125% to &lt;5%), patients with a decreased WHR (\u2264\u22125%) had a significantly attenuated risk of CKD development (HR\u2009=\u20090.300; 95% CI\u2009=\u20090.194\u20130.464). Furthermore, risk reduction from decreased WHR for developing CKD remained significant in non-obese NAFLD patients (HR\u2009=\u20090.290; 95% CI\u2009=\u20090.114\u20130.736). In conclusion, a decrease in WHR of more than 5% significantly reduced the risk of CKD development in NAFLD patients, even in those who were non-obese. Thus, serial monitoring of WHR may be prioritized in the management of NAFLD.<\/jats:p>","DOI":"10.1038\/s41598-020-65940-y","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T10:06:02Z","timestamp":1591092362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Young Eun","family":"Chon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Bum","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Gyu","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Sung","family":"Rim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeonjung","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"65940_CR1","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","volume":"56","author":"G Baffy","year":"2012","unstructured":"Baffy, G., Brunt, E. M. & Caldwell, S. H. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J. Hepatol. 56, 1384\u20131391, https:\/\/doi.org\/10.1016\/j.jhep.2011.10.027 (2012).","journal-title":"J. Hepatol."},{"key":"65940_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.22603","volume":"49","author":"R Vuppalanchi","year":"2009","unstructured":"Vuppalanchi, R. & Chalasani, N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 49, 306\u2013317, https:\/\/doi.org\/10.1002\/hep.22603 (2009).","journal-title":"Hepatology."},{"key":"65940_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64, 73\u201384, https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatology."},{"key":"65940_CR4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 37, 917\u2013923, https:\/\/doi.org\/10.1053\/jhep.2003.50161 (2003).","journal-title":"Hepatology."},{"key":"65940_CR5","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/ajg.2012.314","volume":"107","author":"YM Kwon","year":"2012","unstructured":"Kwon, Y. M. et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am. J. Gastroenterol. 107, 1852\u20131858, https:\/\/doi.org\/10.1038\/ajg.2012.314 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"65940_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/ajg.2011.400","volume":"107","author":"DH Sinn","year":"2012","unstructured":"Sinn, D. H. et al. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am. J. Gastroenterol. 107, 561\u2013567, https:\/\/doi.org\/10.1038\/ajg.2011.400 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"65940_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/liv.12454","volume":"34","author":"NH Kim","year":"2014","unstructured":"Kim, N. H. et al. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects. Liver. Int. 34, 604\u2013611, https:\/\/doi.org\/10.1111\/liv.12454 (2014).","journal-title":"Liver. Int."},{"issue":"9","key":"65940_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"Jeremy Lok Wei","year":"2015","unstructured":"Wei, J. L. et al. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. Am. J. Gastroenterol. 110, 1306-1314; quiz 1315, https:\/\/doi.org\/10.1038\/ajg.2015.235 (2015).","journal-title":"American Journal of Gastroenterology"},{"key":"65940_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim, D. & Kim, W. R. Nonobese Fatty Liver Disease. Clin. Gastroenterol. Hepatol. 15, 474\u2013485, https:\/\/doi.org\/10.1016\/j.cgh.2016.08.028 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"65940_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4291\/wjgp.v8.i3.100","volume":"8","author":"MH Yousef","year":"2017","unstructured":"Yousef, M. H., Al Juboori, A., Albarrak, A. A., Ibdah, J. A. & Tahan, V. Fatty liver without a large \u201cbelly\u201d: Magnified review of non-alcoholic fatty liver disease in non-obese patients. World. J. Gastrointest. Pathophysiol. 8, 100\u2013107, https:\/\/doi.org\/10.4291\/wjgp.v8.i3.100 (2017).","journal-title":"J. Gastrointest. Pathophysiol."},{"key":"65940_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ajg.2016.318","volume":"112","author":"A Feldman","year":"2017","unstructured":"Feldman, A. et al. Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. Am. J. Gastroenterol. 112, 102\u2013110, https:\/\/doi.org\/10.1038\/ajg.2016.318 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"65940_CR12","doi-asserted-by":"publisher","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","volume":"20","author":"RN Feng","year":"2014","unstructured":"Feng, R. N. et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World. J. Gastroenterol. 20, 17932\u201317940, https:\/\/doi.org\/10.3748\/wjg.v20.i47.17932 (2014).","journal-title":"World. J. Gastroenterol."},{"key":"65940_CR13","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","volume":"15","author":"AL Fracanzani","year":"2017","unstructured":"Fracanzani, A. L. et al. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Clin. Gastroenterol. Hepatol. 15, 1604\u20131611 e1601, https:\/\/doi.org\/10.1016\/j.cgh.2017.04.045 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"65940_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep4.1124","volume":"2","author":"H Hagstrom","year":"2018","unstructured":"Hagstrom, H. et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study. Hepatol. Comm. 2, 48\u201357, https:\/\/doi.org\/10.1002\/hep4.1124 (2018).","journal-title":"Hepatol. Comm."},{"key":"65940_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14218\/JCTH.2016.00068","volume":"5","author":"R Kumar","year":"2017","unstructured":"Kumar, R. & Mohan, S. Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications. J. Clin. Transl. Hepatol. 5, 216\u2013223, https:\/\/doi.org\/10.14218\/JCTH.2016.00068 (2017).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"65940_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/apt.14112","volume":"46","author":"S Sookoian","year":"2017","unstructured":"Sookoian, S. & Pirola, C. J. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Alim. Pharmacol. Therapeut. 46, 85\u201395, https:\/\/doi.org\/10.1111\/apt.14112 (2017).","journal-title":"Alim. Pharmacol. Therapeut."},{"key":"65940_CR17","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.2215\/CJN.05050610","volume":"5","author":"G Targher","year":"2010","unstructured":"Targher, G. et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin. J. Am. Soc. Nephrol. 5, 2166\u20132171, https:\/\/doi.org\/10.2215\/CJN.05050610 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"65940_CR18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363, 1341\u20131350, https:\/\/doi.org\/10.1056\/NEJMra0912063 (2010).","journal-title":"N. Engl. J. Med."},{"key":"65940_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","volume":"64","author":"G Targher","year":"2014","unstructured":"Targher, G., Chonchol, M. B. & Byrne, C. D. CKD and nonalcoholic fatty liver disease. Am. J. Kidney. Dis. 64, 638\u2013652, https:\/\/doi.org\/10.1053\/j.ajkd.2014.05.019 (2014).","journal-title":"Am. J. Kidney. Dis."},{"key":"65940_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/apt.13860","volume":"45","author":"E Vilar-Gomez","year":"2017","unstructured":"Vilar-Gomez, E. et al. Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. Alim. Pharmacol. Therapeut. 45, 332\u2013344, https:\/\/doi.org\/10.1111\/apt.13860 (2017).","journal-title":"Alim. Pharmacol. Therapeut."},{"key":"65940_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","volume":"79","author":"A Mantovani","year":"2018","unstructured":"Mantovani, A. et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis. Metabolism. 79, 64\u201376, https:\/\/doi.org\/10.1016\/j.metabol.2017.11.003 (2018).","journal-title":"Metabolism."},{"key":"65940_CR22","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1053\/j.gastro.2016.03.004","volume":"150","author":"G Lassailly","year":"2016","unstructured":"Lassailly, G., Caiazzo, R., Pattou, F. & Mathurin, P. Perspectives on Treatment for Nonalcoholic Steatohepatitis. Gastroenterology. 150, 1835\u20131848, https:\/\/doi.org\/10.1053\/j.gastro.2016.03.004 (2016).","journal-title":"Gastroenterology."},{"key":"65940_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","volume":"56","author":"C Thoma","year":"2012","unstructured":"Thoma, C., Day, C. P. & Trenell, M. I. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J. Hepatol. 56, 255\u2013266, https:\/\/doi.org\/10.1016\/j.jhep.2011.06.010 (2012).","journal-title":"J. Hepatol."},{"issue":"2","key":"65940_CR24","doi-asserted-by":"publisher","first-page":"367-378.e5","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"Eduardo Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez, E. et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 149, 367-378 e365; quiz e314-365, https:\/\/doi.org\/10.1053\/j.gastro.2015.04.005 (2015).","journal-title":"Gastroenterology"},{"key":"65940_CR25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1440-1746.2012.07165.x","volume":"27","author":"YJ Jin","year":"2012","unstructured":"Jin, Y. J. et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J. Gastroenterol. Hepatol. 27, 1341\u20131347, https:\/\/doi.org\/10.1111\/j.1440-1746.2012.07165.x (2012).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"65940_CR26","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1681\/ASN.2005010106","volume":"16","author":"M Kurella","year":"2005","unstructured":"Kurella, M., Lo, J. C. & Chertow, G. M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J. Am. Soc. Nephrol. 16, 2134\u20132140, https:\/\/doi.org\/10.1681\/ASN.2005010106 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"65940_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.mcna.2004.11.003","volume":"89","author":"PT Vlagopoulos","year":"2005","unstructured":"Vlagopoulos, P. T. & Sarnak, M. J. Traditional and nontraditional cardiovascular risk factors in chronic kidney disease. Med. Clin. North. Am. 89, 587\u2013611, https:\/\/doi.org\/10.1016\/j.mcna.2004.11.003 (2005).","journal-title":"Med. Clin. North. Am."},{"key":"65940_CR28","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","volume":"27","author":"ER Smith","year":"2012","unstructured":"Smith, E. R. et al. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol. Dial. Transplant. 27, 1957\u20131966, https:\/\/doi.org\/10.1093\/ndt\/gfr609 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"65940_CR29","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1365-2265.2012.04460.x","volume":"78","author":"T Dogru","year":"2013","unstructured":"Dogru, T. et al. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. Clin. Endocrinol. 78, 712\u2013717, https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04460.x (2013).","journal-title":"Clin. Endocrinol."},{"key":"65940_CR30","doi-asserted-by":"publisher","first-page":"F685","DOI":"10.1152\/ajprenal.00324.2007","volume":"294","author":"KA Griffin","year":"2008","unstructured":"Griffin, K. A., Kramer, H. & Bidani, A. K. Adverse renal consequences of obesity. Am. J. Physiol. Renal. Physiol. 294, F685\u2013696, https:\/\/doi.org\/10.1152\/ajprenal.00324.2007 (2008).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"65940_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen, A. et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 137, 865\u2013872, https:\/\/doi.org\/10.1053\/j.gastro.2009.06.005 (2009).","journal-title":"Gastroenterology."},{"key":"65940_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ng.357","volume":"41","author":"YS Cho","year":"2009","unstructured":"Cho, Y. S. et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Gen. 41, 527\u2013534, https:\/\/doi.org\/10.1038\/ng.357 (2009).","journal-title":"Nat. Gen."},{"key":"65940_CR33","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2215\/CJN.08070910","volume":"6","author":"AM Hung","year":"2011","unstructured":"Hung, A. M. et al. A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin. J. Am. Soc. Nephrol. 6, 767\u2013774, https:\/\/doi.org\/10.2215\/CJN.08070910 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"65940_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4093\/dmj.2011.35.6.561","volume":"35","author":"SW Oh","year":"2011","unstructured":"Oh, S. W. Obesity and metabolic syndrome in Korea. Diabetes. Metab. J. 35, 561\u2013566, https:\/\/doi.org\/10.4093\/dmj.2011.35.6.561 (2011).","journal-title":"Diabetes. Metab. J."},{"key":"65940_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"key":"65940_CR36","first-page":"1","volume":"854","author":"Physical status: the use and interpretation of anthropometry.","year":"1995","unstructured":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World. Health. Organ. Tech. Rep. Ser. 854, 1\u2013452 (1995).","journal-title":"World. Health. Organ. Tech. Rep. Ser."},{"key":"65940_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.soard.2012.11.006","volume":"9","author":"SH Belle","year":"2013","unstructured":"Belle, S. H. et al. Reporting weight change: standardized reporting accounting for baseline weight. Surg. Obes. Relat. Dis. 9, 782\u2013789, https:\/\/doi.org\/10.1016\/j.soard.2012.11.006 (2013).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"65940_CR38","first-page":"370","volume":"17","author":"WH Pan","year":"2008","unstructured":"Pan, W. H. & Yeh, W. T. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia. Pac. J. Clin. Nutr. 17, 370\u2013374 (2008).","journal-title":"J. Clin. Nutr."},{"key":"65940_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3803\/EnM.2014.29.4.405","volume":"29","author":"MK Kim","year":"2014","unstructured":"Kim, M. K. et al. clinical practice guidelines for overweight and obesity in Korea. Endocrino. Metab. 29, 405\u2013409, https:\/\/doi.org\/10.3803\/EnM.2014.29.4.405 (2014).","journal-title":"Endocrino. Metab."},{"key":"65940_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard, A. et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 46, 32\u201336 (2007).","journal-title":"Hepatology."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65940-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65940-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65940-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:45:04Z","timestamp":1670327104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65940-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65940"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65940-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8996"}}